The Lung Cancer Policy Network

The Lung Cancer Policy Network is a global network of multidisciplinary experts from across the lung cancer community, which includes clinicians, researchers, patient organisations and industry partners.

The Network is funded by AstraZeneca, Bristol Myers Squibb Foundation, Guardant Health, Intuitive, Johnson & Johnson, MSD and Siemens Healthineers. Secretariat is provided by The Health Policy Partnership, an independent health research and policy consultancy. All Network outputs are non-promotional, evidence based and shaped by the members, who provide their time for free.